Skip to main content
Anteris Technologies Global Corp. logo

Anteris Technologies Global Corp. — Investor Relations & Filings

Ticker · AVR ISIN · US03675P1021 ASX Manufacturing
Open in API
Filings indexed 1,662 across all filing types
Latest filing 2026-04-23 Regulatory Filings
Country US United States of America
Listing ASX AVR

About Anteris Technologies Global Corp.

https://anteristech.com/

Anteris Technologies is a structural heart company focused on the development and commercialization of medical devices for heart valve disease. Its lead product is the DurAVR® Transcatheter Heart Valve (THV), a biomimetic valve designed for patients with severe aortic stenosis. The DurAVR® THV is engineered to mimic the performance of a healthy human aortic valve, aiming to restore normal, laminar blood flow. Clinical studies have shown the device delivers a favorable hemodynamic profile, characterized by low pressure gradients and a significant reduction in prosthesis-patient mismatch (PPM), even in patients with challenging anatomies. The company is advancing its technology through pivotal clinical trials to establish a new standard in transcatheter aortic valve replacement (TAVR) and improve long-term patient outcomes.

Recent filings

Filing Released Lang Actions
Entry into a Material Definitive Agreement 5 pages 218.2KB
Regulatory Filings Classification · 89% confidence The document is a U.S. SEC Form 8-K current report disclosing entry into a material definitive agreement (a lease), not a full Annual or Quarterly Report nor a dividend, M&A or earnings announcement. It is therefore a general regulatory filing. Under the taxonomy, this falls into the fallback category “Regulatory Filings” (RNS).
2026-04-23 English
Notification regarding unquoted securities - AVR 7 pages 21.1KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 3G - Notification of issue, conversion or payment up of unquoted equity securities' and details the issuance of restricted stock units under an employee incentive scheme. It includes specifics such as the number of securities issued, issue dates, and references to ASX listing rules. The content focuses on the notification of new securities issued, not a financial report or earnings release. This matches the description of a Share Issue/Capital Change announcement, which covers new share issues or capital changes. The document length is 6886 characters, sufficient to contain substantive details of the issuance rather than a brief announcement or report publication notice. Therefore, the appropriate classification is Share Issue/Capital Change (SHA).
2026-04-13 English
Application for quotation of securities - AVR 6 pages 18.6KB
Share Issue/Capital Change Classification · 100% confidence The document is titled 'Appendix 2A - Application for quotation of securities' and details the application for quotation of securities on the ASX (Australian Securities Exchange). It includes information about securities issued due to options exercised or convertible securities converted, the number of securities to be quoted, issue dates, and details about the securities class and issued capital. This is a formal announcement related to the listing or quotation of securities rather than a financial report, earnings release, or management discussion. It fits the category of Share Issue/Capital Change announcements, as it concerns the issuance and quotation of new securities and changes in capital structure.
2026-04-12 English
Statement of CDIs on issue - AVR 3 pages 12.9KB
Regulatory Filings Classification · 95% confidence The document is titled 'Appendix 4A - Statement of CDIs on issue' and provides detailed monthly data on the number and class of CHESS Depositary Interests (CDIs) and other securities issued by Anteris Technologies Global Corp. It includes net differences in securities issued between months and reasons for changes, such as transfers between CDIs and common stock on Nasdaq. The document is a regulatory announcement related to securities on issue rather than a financial report, earnings release, or management discussion. It is a typical format for a securities statement filed with the ASX to update on capital structure and securities issued. Given the nature and length (3225 characters), it is not a full financial report but a regulatory filing about securities issued. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2026-04-06 English
Notification of cessation of securities - AVR 5 pages 18.3KB
Regulatory Filings Classification · 95% confidence The document is titled 'Appendix 3H - Notification of cessation of securities' and details the lapse or cessation of various securities such as restricted stock units and options for the entity Anteris Technologies Global Corp. It provides specific information about the securities that have ceased, reasons for cessation, dates, and the resulting issued capital. This type of document is a regulatory announcement notifying the market and shareholders about changes in the status of securities, specifically cessation or lapsing of securities. It is not a financial report, earnings release, or management discussion. It is also not a voting result or capital raising announcement. The document fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement about securities status changes that do not fit into more specific categories like share issue or director dealings. The document length and detail confirm it is not a brief report publication announcement but a substantive regulatory notice.
2026-03-31 English
424B3 - Anteris Technologies Global Corp. (0002011514) (Filer)
Regulatory Filings
2026-03-18 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.